The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global BCG Vaccine Market Research Report 2024
Synopsis
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
The global BCG Vaccine market was valued at US$ 373.7 million in 2023 and is anticipated to reach US$ 549.7 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
This report aims to provide a comprehensive presentation of the global market for BCG Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine.
Report Scope
The BCG Vaccine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BCG Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Segment by Type
Immune BCG
Therapy BCG
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guérin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
The global BCG Vaccine market was valued at US$ 373.7 million in 2023 and is anticipated to reach US$ 549.7 million by 2030, witnessing a CAGR of 5.6% during the forecast period 2024-2030.
Japan is the largest BCG Vaccine market with about 30% market share. North America is follower, accounting for about 29% market share.The key manufacturers are Merck, Sanofi Pasteur, Japan BCG Lab, China National Biotec, Serum Institute of India, Intervax, GSBPL etc. Top 3 companies occupied about 77% market share.
This report aims to provide a comprehensive presentation of the global market for BCG Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding BCG Vaccine.
Report Scope
The BCG Vaccine market size, estimations, and forecasts are provided in terms of sales volume (MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global BCG Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the BCG Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Segment by Type
Immune BCG
Therapy BCG
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of BCG Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of BCG Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 BCG Vaccine Market Overview
1.1 Product Overview and Scope of BCG Vaccine
1.2 BCG Vaccine Segment by Type
1.2.1 Global BCG Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Immune BCG
1.2.3 Therapy BCG
1.3 BCG Vaccine Segment by Application
1.3.1 Global BCG Vaccine Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global BCG Vaccine Market Size Estimates and Forecasts
1.4.1 Global BCG Vaccine Revenue 2019-2030
1.4.2 Global BCG Vaccine Sales 2019-2030
1.4.3 Global BCG Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 BCG Vaccine Market Competition by Manufacturers
2.1 Global BCG Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global BCG Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global BCG Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global BCG Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of BCG Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of BCG Vaccine, Product Type & Application
2.7 BCG Vaccine Market Competitive Situation and Trends
2.7.1 BCG Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest BCG Vaccine Players Market Share by Revenue
2.7.3 Global BCG Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 BCG Vaccine Retrospective Market Scenario by Region
3.1 Global BCG Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global BCG Vaccine Global BCG Vaccine Sales by Region: 2019-2030
3.2.1 Global BCG Vaccine Sales by Region: 2019-2024
3.2.2 Global BCG Vaccine Sales by Region: 2025-2030
3.3 Global BCG Vaccine Global BCG Vaccine Revenue by Region: 2019-2030
3.3.1 Global BCG Vaccine Revenue by Region: 2019-2024
3.3.2 Global BCG Vaccine Revenue by Region: 2025-2030
3.4 North America BCG Vaccine Market Facts & Figures by Country
3.4.1 North America BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America BCG Vaccine Sales by Country (2019-2030)
3.4.3 North America BCG Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe BCG Vaccine Market Facts & Figures by Country
3.5.1 Europe BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe BCG Vaccine Sales by Country (2019-2030)
3.5.3 Europe BCG Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific BCG Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific BCG Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific BCG Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America BCG Vaccine Market Facts & Figures by Country
3.7.1 Latin America BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America BCG Vaccine Sales by Country (2019-2030)
3.7.3 Latin America BCG Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa BCG Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa BCG Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa BCG Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa BCG Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global BCG Vaccine Sales by Type (2019-2030)
4.1.1 Global BCG Vaccine Sales by Type (2019-2024)
4.1.2 Global BCG Vaccine Sales by Type (2025-2030)
4.1.3 Global BCG Vaccine Sales Market Share by Type (2019-2030)
4.2 Global BCG Vaccine Revenue by Type (2019-2030)
4.2.1 Global BCG Vaccine Revenue by Type (2019-2024)
4.2.2 Global BCG Vaccine Revenue by Type (2025-2030)
4.2.3 Global BCG Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global BCG Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global BCG Vaccine Sales by Application (2019-2030)
5.1.1 Global BCG Vaccine Sales by Application (2019-2024)
5.1.2 Global BCG Vaccine Sales by Application (2025-2030)
5.1.3 Global BCG Vaccine Sales Market Share by Application (2019-2030)
5.2 Global BCG Vaccine Revenue by Application (2019-2030)
5.2.1 Global BCG Vaccine Revenue by Application (2019-2024)
5.2.2 Global BCG Vaccine Revenue by Application (2025-2030)
5.2.3 Global BCG Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global BCG Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck BCG Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur
6.2.1 Sanofi Pasteur Corporation Information
6.2.2 Sanofi Pasteur Description and Business Overview
6.2.3 Sanofi Pasteur BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur BCG Vaccine Product Portfolio
6.2.5 Sanofi Pasteur Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Japan BCG Lab BCG Vaccine Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 China National Biotec
6.4.1 China National Biotec Corporation Information
6.4.2 China National Biotec Description and Business Overview
6.4.3 China National Biotec BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 China National Biotec BCG Vaccine Product Portfolio
6.4.5 China National Biotec Recent Developments/Updates
6.5 Serum Institute of India
6.5.1 Serum Institute of India Corporation Information
6.5.2 Serum Institute of India Description and Business Overview
6.5.3 Serum Institute of India BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Serum Institute of India BCG Vaccine Product Portfolio
6.5.5 Serum Institute of India Recent Developments/Updates
6.6 Intervax
6.6.1 Intervax Corporation Information
6.6.2 Intervax Description and Business Overview
6.6.3 Intervax BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Intervax BCG Vaccine Product Portfolio
6.6.5 Intervax Recent Developments/Updates
6.7 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL BCG Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 GSBPL BCG Vaccine Product Portfolio
6.7.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 BCG Vaccine Industry Chain Analysis
7.2 BCG Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 BCG Vaccine Production Mode & Process
7.4 BCG Vaccine Sales and Marketing
7.4.1 BCG Vaccine Sales Channels
7.4.2 BCG Vaccine Distributors
7.5 BCG Vaccine Customers
8 BCG Vaccine Market Dynamics
8.1 BCG Vaccine Industry Trends
8.2 BCG Vaccine Market Drivers
8.3 BCG Vaccine Market Challenges
8.4 BCG Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
